FDA approves Xofluza to treat influenza in those at high risk of influenza complications Oct. 18, 2019
FDA approves Invokana for use in patients with type 2 diabetes and diabetic kidney disease Oct. 1, 2019
FDA approves Rituxan for pediatric granulomatosis with polyangiitis and microscopic polyangiitis Sep. 30, 2019
RSS